Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hadi Bagheri

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Current Oncology (Toronto, Ont.)|December 13, 2021
Tumor Doubling Time Using CT Volumetric Segmentation in Metastatic Adrenocortical CarcinomaSarah N Fuller, Ahmad Shafiei, David J Venzon, et al.
Journal of Research in Health Sciences|January 11, 2021
The Epidemiology of Aggression and Associated Factors among Iranian Adult Population: A National SurveyJalal Poorolajal, Bahram Ebrahimi, Forouzan Rezapur-Shahkolai, et al.
Cancers|July 20, 2021
Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung AdenocarcinomaChul Kim, Liqiang Xi, Constance M Cultraro, et al.
Frontiers in Oncology|January 3, 2022
Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical EfficacyHoyoung M Maeng, Brittni N Moore, Hadi Bagheri, et al.
Nature Medicine|February 9, 2021
TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancersNisha B Nagarsheth, Scott M Norberg, Andrew L Sinkoe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2022
Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor TherapyDaniel M Girardi, Scot A Niglio, Amir Mortazavi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2020
Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary TumorsAndrea B Apolo, Rosa Nadal, Daniel M Girardi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2024
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary TumorsAndrea B Apolo, Daniel M Girardi, Scot A Niglio, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Current Oncology (Toronto, Ont.)|December 13, 2021
Tumor Doubling Time Using CT Volumetric Segmentation in Metastatic Adrenocortical CarcinomaSarah N Fuller, Ahmad Shafiei, David J Venzon, et al.
Journal of Research in Health Sciences|January 11, 2021
The Epidemiology of Aggression and Associated Factors among Iranian Adult Population: A National SurveyJalal Poorolajal, Bahram Ebrahimi, Forouzan Rezapur-Shahkolai, et al.
Cancers|July 20, 2021
Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung AdenocarcinomaChul Kim, Liqiang Xi, Constance M Cultraro, et al.
Frontiers in Oncology|January 3, 2022
Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical EfficacyHoyoung M Maeng, Brittni N Moore, Hadi Bagheri, et al.
Nature Medicine|February 9, 2021
TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancersNisha B Nagarsheth, Scott M Norberg, Andrew L Sinkoe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2022
Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor TherapyDaniel M Girardi, Scot A Niglio, Amir Mortazavi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2020
Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary TumorsAndrea B Apolo, Rosa Nadal, Daniel M Girardi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2024
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary TumorsAndrea B Apolo, Daniel M Girardi, Scot A Niglio, et al.
Pageof 6